Categories: Business

Benchmarks set to open higher after Modi agrees to trade negotiations with Trump

The benchmark indexes are set to open higher on Friday after U.S. President Donald Trump said the Indian Prime Ministefr offered to talk about easing tariffs, easing some worries over reciprocal duties.

The GIFT Nifty futures were trading at 23,195 as of 08:30 a.m. IST, indicating that the blue-chip Nifty 50 will open above Thursday’s close of 23,031.4.

The Nifty has opened either flat or marginally positive in each of the last seven sessions but failed to sustain gains.

Both the benchmarks – Nifty 50 and BSE Sensex – have lost about 3% each over the seven sessions on sustained foreign selling and mounting concerns around U.S. trade policy.

Foreign portfolio investors have sold Indian shares worth $11.23 billion so far this year.

PM Narendra Modi offered to talk about easing tariffs, buying more US oil and gas, combat aircraft and concessions, Trump said on Thursday after he met Modi at the White House, setting the stage for trade negotiations.

Trump is devising plans for reciprocal tariffs on every country taxing US imports, heightening the prospects of a global trade war.

India will be impacted by reciprocal tariffs due to the pronounced tariff differentials with the U.S., according to several brokerages.

However, Trump’s tariffs will not be imposed right away.

Howard Lutnick, Trump’s pick for commerce secretary, said the administration would address each affected country and studies on the issue would be completed by April 1.

Other Asian markets gained on relief that the reciprocal tariff plan will not be implemented immediately.

Wall Street equities gained after an inflation reading fuelled hopes that the Federal Reserve’s preferred measure of inflation might be cooler than anticipated.

STOCKS TO WATCH

** Aluminium and copper producer Hindalco Industries beats quarterly profit view on improved aluminum prices.

** Deepak Nitrite posts drop in December quarter profit

** KNR Constructions reports rise in December quarter profit

** European Commission grants marketing authorization for a biosimilar of Aurobindo Pharma

Source link

nasdaqpicks.com

Share
Published by
nasdaqpicks.com

Recent Posts

Axis Securities penalised ₹10 lakh by Sebi for flouting stock broker rules

Capital markets regulator Sebi has imposed a penalty of ₹10 lakh on Axis Securities for…

11 minutes ago

Target hit by consumer anger at its retreat from diversity policies

Target has become the focus of consumer anger at the corporate retreat from diversity policies…

25 minutes ago

SLBC Tunnel Mishap Highlights: 8 workers trapped, 13 injured; rescue operations underway

Eight persons were trapped inside after a section of roof collapsed in the under construction…

31 minutes ago

Pi Network Coin: ‘Hold your precious coins!’ Crypto experts see further upside after Pi recovers 73% from day one crash

Crypto expert Kim H Wong believes trading in Pi is disappointing as pioneers keep selling…

33 minutes ago

Experts bat for diversification in plantation sector to boost business

Plantation experts have emphasised the need for diversification into multi cropping, agro forestry including silviculture…

38 minutes ago

Balrampur Chini plans to start PLA production by 2026-end

Uttar PradeshBalrampur Chini Mills, which is planning to start commercial production of polylactic acid (PLA)…

45 minutes ago